Pinnacle West Asset Management Inc. Has $3.59 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Pinnacle West Asset Management Inc. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,105 shares of the healthcare conglomerate’s stock after selling 25 shares during the period. UnitedHealth Group makes up about 2.6% of Pinnacle West Asset Management Inc.’s investment portfolio, making the stock its 6th largest holding. Pinnacle West Asset Management Inc.’s holdings in UnitedHealth Group were worth $3,594,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of UNH. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $30,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group in the third quarter worth $37,000. DecisionPoint Financial LLC grew its holdings in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after acquiring an additional 62 shares during the period. Highline Wealth Partners LLC bought a new stake in shares of UnitedHealth Group in the third quarter worth $55,000. Finally, Legacy Investment Solutions LLC bought a new stake in shares of UnitedHealth Group in the third quarter worth $57,000. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of several research analyst reports. Piper Sandler cut their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Oppenheimer lifted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Finally, Barclays lowered their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $629.32.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Trading Up 1.9 %

Shares of UNH stock opened at $470.49 on Wednesday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock’s 50-day moving average price is $518.22 and its 200-day moving average price is $559.08. The stock has a market capitalization of $432.99 billion, a price-to-earnings ratio of 30.35, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the firm posted $5.83 earnings per share. The business’s revenue was up 6.8% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.79%. UnitedHealth Group’s payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.